Published in Drug Saf on June 18, 1991
Safety of fluoroquinolones: An update. Can J Infect Dis (2002) 1.17
Safety and tolerability of fluoroquinolones. Drugs (1993) 0.96
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine. Clin Pharmacokinet (1992) 0.93
Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria. Biomed Res Int (2016) 0.75
Neurotoxicodynamics of the interaction between ciprofloxacin and foscarnet in mice. Antimicrob Agents Chemother (1998) 0.75
In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system. Antimicrob Agents Chemother (1999) 0.75
Trimethoprim--sulphamethoxazole: comparative study in urinary infection in hospital. Br Med J (1969) 3.68
In-vitro studies with ciprofloxacin, a new 4-quinolone compound. J Antimicrob Chemother (1984) 3.62
Quality control of serum gentamicin assays--experience of national surveys. J Antimicrob Chemother (1975) 3.08
R Factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet (1971) 3.01
Screening of urines with dipstrips: does it reduce workload and consumable costs? J Clin Pathol (1990) 2.68
Sulphamethoxazole-trimethoprim: the first two years. J Clin Pathol (1971) 2.59
Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints. J Antimicrob Chemother (1998) 2.42
Audit of turn-around times in a microbiology laboratory. J Clin Pathol (1991) 2.38
Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet (1971) 2.36
Epidemic infection by a gentamicin-resistant Staphylococcus aureus in three hospitals. Lancet (1976) 2.24
Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic. Chemotherapy (1974) 1.97
Needlestick injuries among medical students. J Hosp Infect (1993) 1.96
Theatre over-shoes do not reduce operating theatre floor bacterial counts. J Hosp Infect (1991) 1.92
The acetyltransferase enzyme method for the assay of serum gentamicon concentrations and a comparison with other methods. J Clin Pathol (1975) 1.88
Immunosuppressive powers of the antibacterial agent trimethoprim. Nature (1970) 1.75
Talampicillin: a new derivative of ampicillin. Br Med J (1976) 1.71
Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect (1997) 1.60
Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation. Br Med J (1971) 1.58
A laboratory evaluation of a novel (beta-lactam antibiotic mecillinam. J Antimicrob Chemother (1975) 1.57
Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections. BMJ (1994) 1.52
An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2004) 1.51
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs (1988) 1.48
Audits of antibiotic prescribing in a Bristol hospital. Br Med J (Clin Res Ed) (1983) 1.47
Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. J Antimicrob Chemother (1997) 1.46
Antibacterial activity of mecillinam. J Antimicrob Chemother (1977) 1.44
Assay of gentamicin. Lancet (1972) 1.41
Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics. Arzneimittelforschung (1979) 1.39
The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity. J Antimicrob Chemother (1984) 1.37
Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin. Infection (1976) 1.35
5-fluorocytosine and urinary candidiasis. Br Med J (1971) 1.34
Human metabolism of cefotaxime. J Antimicrob Chemother (1980) 1.34
Prophylactic oral fluconazole and candida fungaemia. Lancet (1991) 1.33
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V. Infection (1994) 1.31
Comparison of sensititre dried microtitration trays with a standard agar method for determination of minimum inhibitory concentrations of antimicrobial agents. Antimicrob Agents Chemother (1980) 1.30
AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin. J Antimicrob Chemother (1987) 1.26
Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. J Antimicrob Chemother (1997) 1.25
First multiresistant pneumococcus in Britain. Br Med J (Clin Res Ed) (1987) 1.23
Mupirocin-resistant Staphylococcus aureus. Lancet (1990) 1.22
Cloning and characterization of an AAC(6') gene from Serratia marcescens. J Antimicrob Chemother (1988) 1.22
Is coagulase-negative staphylococcal bacteraemia in neonates a consequence of mechanical ventilation? J Hosp Infect (1984) 1.22
Pre-incisional intraparietal injection of cephamandole: a new approach to wound infection prophylaxis. Br J Surg (1982) 1.21
An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother (1993) 1.19
Measurement of urinary lipopolysaccharide antibodies by ELISA as a screen for urinary tract infection. J Clin Pathol (1991) 1.18
The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources. Int J Food Microbiol (1994) 1.17
Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations with particular reference to the treatment of urinary infections. Postgrad Med J (1969) 1.17
Once-daily aminoglycoside dosing. Lancet (1993) 1.15
Antibiotic-resistant Escherichia coli causing urinary-tract infection in general practice: relation to faecal flora. Lancet (1971) 1.13
Properties of the gentamicin acetyltransferase enzyme and application to the assay of aminoglycoside antibiotics. Antimicrob Agents Chemother (1975) 1.09
Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp. J Antimicrob Chemother (1981) 1.07
Outbreaks of hospital infection in southwest England caused by gentamicin-resistant Serratia marcescens. J Hosp Infect (1982) 1.06
The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Infection (1979) 1.05
An evaluation of a gentamicin fluoroimmunoassay kit; correlation with radioimmunoassay, acetyl transferase and microbiological assay. J Antimicrob Chemother (1980) 1.04
Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study. J Antimicrob Chemother (1984) 1.04
Typing of Listeria spp. by random amplified polymorphic DNA (RAPD) analysis. J Med Microbiol (1993) 1.04
Zidovudine after occupational exposure to HIV. BMJ (1991) 1.03
Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty. J Antimicrob Chemother (1990) 1.03
Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target. J Chemother (1996) 1.01
Perineal cleansing before midstream urine, a necessary ritual. Lancet (1979) 1.01
Serum aminoglycoside assay by enzyme-mediated immunoassay (EMIT): correlation with radioimmunoassay, microbiological assays. Antimicrob Agents Chemother (1981) 1.01
The effect of surgical theatre head-gear on air bacterial counts. J Hosp Infect (1991) 1.00
Resistance to ciprofloxacin. Lancet (1985) 0.99
The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria. J Antimicrob Chemother (1996) 0.99
Evaluation of API 20 STREP system for identifying Listeria species. J Clin Pathol (1989) 0.98
The treatment of bacteriuria in pregnant women with sulphamethoxazole and thrimethoprim. A microbiological, clinical and toxicological study. Postgrad Med J (1969) 0.97
Secretion of the antibacterial substance trimethoprim in the prostatic fluid of dogs. Br J Urol (1970) 0.97
Stabilization of cephalosporins in serum and plasma. J Antimicrob Chemother (1979) 0.96
Pelvic tissue and serum concentrations of various antibiotics given as pre-operative medication. Br J Obstet Gynaecol (1977) 0.96
Comparative activity in vitro of piperacillin. J Antimicrob Chemother (1982) 0.96
Letter: Chickenpox from herpes zoster. Br Med J (1974) 0.96
Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net. J Antimicrob Chemother (1997) 0.95
In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur J Clin Microbiol Infect Dis (1990) 0.94
The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials. J Antimicrob Chemother (1986) 0.93
Identification of aminoglycoside-acetylating enzymes by high-pressure liquid chromatographic determination of their reaction products. Antimicrob Agents Chemother (1984) 0.92
Antibiotic resistance of Listeria monocytogenes. Lancet (1990) 0.92
Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. J Antimicrob Chemother (1988) 0.92
A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone. J Antimicrob Chemother (1996) 0.92
The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics. Curr Med Res Opin (1985) 0.92
A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect (1994) 0.91
Comparative in-vitro activity of Sch 29482, a new penem antibiotic. J Antimicrob Chemother (1982) 0.91
Gentamicin in the treatment of gonococcal urethritis. A microbiological, pharmacological, and clinical study. Br J Vener Dis (1973) 0.91
Bacterial colonization of the non-pregnant uterus: a study of pre-menopausal abdominal hysterectomy specimens. Eur J Clin Microbiol Infect Dis (1992) 0.91
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1981. N Engl J Med (1981) 0.90
Comparative activity in vitro of ceftazidime and nine other antibacterial agents. Infection (1983) 0.90
The effects of swaddling versus standard positioning on neuromuscular development in very low birth weight infants. Neonatal Netw (1996) 0.90
Listeria faecal carriage by renal transplant recipients, haemodialysis patients and patients in general practice: its relation to season, drug therapy, foreign travel, animal exposure and diet. Epidemiol Infect (1991) 0.90
Laboratory and clinical studies with sulfametopyrazine as a treatment for bacteriuria in pregnancy. J Antimicrob Chemother (1975) 0.89
A 10 year survey of the epidemiology and clinical aspects of listeriosis in a provincial English city. J Infect (1994) 0.89
The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline. J Antimicrob Chemother (1988) 0.88
Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis. J Antimicrob Chemother (1983) 0.88
The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. J Pharmacokinet Biopharm (1985) 0.88
Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans. J Antimicrob Chemother (1998) 0.88
The pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous i.v. administration. J Antimicrob Chemother (1990) 0.88
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol (1986) 0.87
A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative beta-lactam, aminoglycoside and fluoroquinolone. J Antimicrob Chemother (1995) 0.87
In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes. J Antimicrob Chemother (1990) 0.87
Serum monitoring of teicoplanin. J Antimicrob Chemother (1992) 0.87
Cefuroxime resistance in Haemophilus influenzae. Lancet (1992) 0.86
Letter: Quality control of gentamicin assays. Lancet (1974) 0.86
Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma. J Infect (1994) 0.86
Resolution of antibiotic mixtures in serum samples by high-voltage electrophoresis. J Clin Pathol (1975) 0.86